Acceleron

Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Motley Fool
Celgene
Juno Therapeutics
Acceleron
Bluebird Bio
Flag link:
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug
Xtalks
Acceleron
renal cell carcinoma
clinical trials
Axitinib
Flag link:
Ac­celeron dumps dalantercept after kidney cancer trial fail
Ac­celeron dumps dalantercept after kidney cancer trial fail
Fierce Biotech
Acceleron
dalantercept
kidney cancer
clinical trials
Flag link:
The Most Important Keys To Celgene's Pipeline
The Most Important Keys To Celgene's Pipeline
Seeking Alpha
Celgene
Revlimid
Acceleron
Juno Therapeutics
Agios
Flag link:
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Celgene and Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Yahoo
Celgene
Acceleron
myelodysplastic syndromes
MDS
luspatercept
Flag link:
Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters
Acceleron Pharma Has 2 Drug Candidates That Could Become Blockbusters
Seeking Alpha
Acceleron
luspatercept
Celgene
dalantercept
Flag link:
A pair of Celgene partners gets on the FDA fast track
A pair of Celgene partners gets on the FDA fast track
Fierce Biotech
Celgene
FDA
fast track
luspatercept
Acceleron
beta-thalassemia
AG-120
Agios Pharmaceuticals
Flag link:
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Flag link:
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline
TheStreet.com
Acceleron
Bluebird Bio
Flag link:
3 Biggest Biotech Crashes in March
3 Biggest Biotech Crashes in March
Motley Fool
Acceleron
Celldex Therapeutics
NewLink Genetics
Flag link:
[video]Biotech CEO looks down the pipeline for growth
[video]Biotech CEO looks down the pipeline for growth
CNBC
Acceleron
Flag link:
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
The State of Gene Therapy in a Biogen Idec World: Sangamo, Bluebird and Acceleron
TheStreet.com
gene therapy
Biogen Idec
Sangamo BioSciences
Bluebird Bio
Acceleron
Flag link:
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Amgen
Acceleron
Celgene
anemia
sotatercept
ACE-536
Flag link:
ASH Conference: 3 Companies To Watch
ASH Conference: 3 Companies To Watch
Seeking Alpha
Stemline Therapeutics
Portola
Acceleron
Flag link:
Acceleron: A Small Biotech Preparing To Supply Big Markets
Acceleron: A Small Biotech Preparing To Supply Big Markets
Seeking Alpha
Acceleron
Amgen
Celgene
IPOs
Flag link:
Acceleron Pharma - Successful Cancer Research IPO
Acceleron Pharma - Successful Cancer Research IPO
Seeking Alpha
Acceleron
Flag link:
[video]Biotech IPOs With Big Partners
[video]Biotech IPOs With Big Partners
TheStreet.com
biotech
IPOs
Celgene
Amgen
Bind Therapeutics
Acceleron
Fate Therapeutics
Flag link:
Acceleron Receives Two FDA Orphan Designations for ACE-536
Acceleron Receives Two FDA Orphan Designations for ACE-536
Yahoo
FDA
orphan drugs
ACE-536
Acceleron
beta-thalassemia
myelodysplastic syndromes
Flag link:
Acceleron inks $498M pact with Shire for lead muscle drug
Acceleron inks $498M pact with Shire for lead muscle drug
Fierce Biotech
Shire
Acceleron
Flag link:
Alkermes, Acceleron in $10M licensing deal
Alkermes, Acceleron in $10M licensing deal
Fierce Biotech
Acceleron
licensing
Alkermes
Flag link: